Dr. Simone Discusses the Precision Promise Trial in Pancreatic Cancer
May 23rd 2018Diane Simeone, MD, director, Pancreatic Cancer Center, associate director, Translational Research, NYU Langone’s Perlmutter Cancer Center, discusses the Precision Promise trial for patients with metastastic pancreatic cancer.
Read More
Dr. Simeone on the Importance of Mutational Analysis in Patients With Pancreatic Cancer
May 5th 2018Diane Simeone, MD, director, Pancreatic Cancer Center, associate director, Translational Research, NYU Langone’s Perlmutter Cancer Center, discusses the importance of mutational analysis in the treatment of patients with pancreatic cancer.
Read More